Inge Marie Svane (Inge M Svane)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 56

Top Venues

Cancers

Oncoimmunology

Acta oncologica (Stockholm, Sweden)

Clinical cancer research : an official journal of the American Association for Cancer Research

Center for Cancer Immune Therapy

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Center for Cancer Immune Therapy

Denmark

Professor, MD, Director :: Department of Oncology and Hematology, Herlev Hospital

Publications

Ervin Ascic, Fritiof Åkerström, Malavika Sreekumar Nair, André Rosa, Ilia Kurochkin, Olga Zimmermannova, Xavier Catena, Nadezhda Rotankova, Charlotte Veser, Michal Rudnik, Tommaso Ballocci, Tiffany Schärer, Xiaoli Huang, Maria de Rosa Torres, Emilie Renaud, Marta Velasco Santiago, Özcan Met, David Askmyr, Malin Lindstedt, Lennart Greiff, Laure-Anne Ligeon, Irina Agarkova, Inge Marie Svane, Cristiana F Pires, Fábio F Rosa, Carlos-Filipe Pereira
In vivo dendritic cell reprogramming for cancer immunotherapy. Science (New York, N.Y.) (2024)
Alice Markussen, Julia Sidenius Johansen, Finn O Larsen, Susann Theile, Jane P Hasselby, Gro L Willemoe, Torben Lorentzen, Kasper Madsen, Estrid V S Høgdall, Tim Svenstrup Poulsen, Eva E Wilken, Poul Geertsen, Claus Preibisch Behrens, Inge Marie Svane, Dorte Lisbet Nielsen, Inna Markovna Chen
Nivolumab With or Without Ipilimumab Combined with Stereotactic Body Radiotherapy in patients with Metastatic Biliary Tract Cancer: A Randomized Phase 2 Study. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Marco Donia, Inge Marie Svane
Harnessing neoantigen-specific T cells for precision cancer immunotherapy. Nature reviews. Clinical oncology 21 (4) (2024)
Signe Koggersbøl Skadborg, Simone Maarup, Arianna Draghi, Annie Borch, Sille Hendriksen, Filip Mundt, Vilde Pedersen, Matthias Mann, Ib Jarle Christensen, Jane Skjøth-Rasmussen, Christina Westmose Yde, Bjarne Winther Kristensen, Hans Skovgaard Poulsen, Benedikte Hasselbalch, Inge Marie Svane, Ulrik N Lassen, Sine Reker Hadrup
Nivolumab Reaches Brain Lesions in Patients with Recurrent Glioblastoma and Induces T-cell Activity and Upregulation of Checkpoint Pathways. Cancer immunology research 12 (9) (2024)
Sif Homburg, Charlotte Birk Christensen, Magnus Pedersen, Simon Grund Sørensen, Marco Donia, Inge Marie Svane, Helle Westergren Hendel, Eva Ellebaek
Prospective Assessment of Fluorine-18-Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography (FDG-PET/CT) for Early Identification of Checkpoint-Inhibitor-Induced Pseudoprogression. Cancers 16 (5) (2024)
Martin Lauss, Bengt Phung, Troels Holz Borch, Katja Harbst, Kamila Kaminska, Anna Ebbesson, Ingrid Hedenfalk, Joan Yuan, Kari Nielsen, Christian Ingvar, Ana Carneiro, Karolin Isaksson, Kristian Pietras, Inge Marie Svane, Marco Donia, Göran Jönsson
Molecular patterns of resistance to immune checkpoint blockade in melanoma. Nature communications 15 (1) (2024)
Karoline Dreyer Kattenhøj, Christine Louise Møberg, Louise Mahncke Guldbrandt, Rasmus Blechingberg Friis, Christophe Kamungu Mapendano, Søren Kjær Petersen, Christina Halgaard Bruvik Ruhlmann, Inge Marie Svane, Marco Donia, Eva Ellebaek, Henrik Schmidt
Efficacy of Ipilimumab and Nivolumab in Patients with Melanoma and Brain Metastases-A Danish Real-World Cohort. Cancers 16 (14) (2024)
Karoline Dreyer Kattenhøj, Christine Louise Møberg, Louise Mahncke Guldbrandt, Rasmus Blechingberg Friis, Christophe Kamungu Mapendano, Søren Kjær Petersen, Christina Halgaard Bruvik Ruhlmann, Inge Marie Svane, Marco Donia, Eva Ellebaek, Henrik Schmidt
Efficacy of Ipilimumab and Nivolumab in Patients with Melanoma and Brain Metastases-A Danish Real-World Cohort. Cancers 16 (14) (2024)
Martin Lauss, Bengt Phung, Troels Holz Borch, Katja Harbst, Kamila Kaminska, Anna Ebbesson, Ingrid Hedenfalk, Joan Yuan, Kari Nielsen, Christian Ingvar, Ana Carneiro, Karolin Isaksson, Kristian Pietras, Inge Marie Svane, Marco Donia, Göran Jönsson
Molecular patterns of resistance to immune checkpoint blockade in melanoma. Nature communications 15 (1) (2024)
Sidsel Pedersen, Marc Østergaard Nielsen, Marco Donia, Inge Marie Svane, Bo Zerahn, Eva Ellebaek
Real-World Cardiotoxicity in Metastatic Melanoma Patients Treated with Encorafenib and Binimetinib. Cancers 16 (17) (2024)
Sif Homburg, Charlotte Birk Christensen, Magnus Pedersen, Simon Grund Sørensen, Marco Donia, Inge Marie Svane, Helle Westergren Hendel, Eva Ellebaek
Prospective Assessment of Fluorine-18-Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography (FDG-PET/CT) for Early Identification of Checkpoint-Inhibitor-Induced Pseudoprogression. Cancers 16 (5) (2024)
Signe Koggersbøl Skadborg, Simone Maarup, Arianna Draghi, Annie Borch, Sille Hendriksen, Filip Mundt, Vilde Pedersen, Matthias Mann, Ib Jarle Christensen, Jane Skjøth-Rasmussen, Christina Westmose Yde, Bjarne Winther Kristensen, Hans Skovgaard Poulsen, Benedikte Hasselbalch, Inge Marie Svane, Ulrik N Lassen, Sine Reker Hadrup
Nivolumab reaches brain lesions in patients with recurrent glioblastoma and induces T-cell activity and upregulation of checkpoint pathways. Cancer immunology research (2024)
Martin Lauss, Bengt Phung, Troels Holz Borch, Katja Harbst, Kamila Kaminska, Anna Ebbesson, Ingrid Hedenfalk, Joan Yuan, Kari Nielsen, Christian Ingvar, Ana Carneiro, Karolin Isaksson, Kristian Pietras, Inge Marie Svane, Marco Donia, Göran Jönsson
Molecular patterns of resistance to immune checkpoint blockade in melanoma. Nature communications 15 (1) (2024)
Karoline Dreyer Kattenhøj, Christine Louise Møberg, Louise Mahncke Guldbrandt, Rasmus Blechingberg Friis, Christophe Kamungu Mapendano, Søren Kjær Petersen, Christina Halgaard Bruvik Ruhlmann, Inge Marie Svane, Marco Donia, Eva Ellebaek, Henrik Schmidt
Efficacy of Ipilimumab and Nivolumab in Patients with Melanoma and Brain Metastases-A Danish Real-World Cohort. Cancers 16 (14) (2024)
Marco Donia, Inge Marie Svane
Harnessing neoantigen-specific T cells for precision cancer immunotherapy. Nature reviews. Clinical oncology (2024)
Martin Lauss, Bengt Phung, Troels Holz Borch, Katja Harbst, Kamila Kaminska, Anna Ebbesson, Ingrid Hedenfalk, Joan Yuan, Kari Nielsen, Christian Ingvar, Ana Carneiro, Karolin Isaksson, Kristian Pietras, Inge Marie Svane, Marco Donia, Göran Jönsson
Molecular patterns of resistance to immune checkpoint blockade in melanoma. Nature communications 15 (1) (2024)
Alice Markussen, Julia Sidenius Johansen, Finn O Larsen, Susann Theile, Jane P Hasselby, Gro L Willemoe, Torben Lorentzen, Kasper Madsen, Estrid V S Høgdall, Tim Svenstrup Poulsen, Eva E Wilken, Poul Geertsen, Claus Preibisch Behrens, Inge Marie Svane, Dorte Lisbet Nielsen, Inna Markovna Chen
Nivolumab with or without Ipilimumab Combined with Stereotactic Body Radiotherapy in Patients with Metastatic Biliary Tract Cancer: A Randomized Phase 2 Study. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (16) (2024)
Arianna Draghi, Mario Presti, Agnete Witness Præst Jensen, Christopher Aled Chamberlain, Benedetta Albieri, Anne-Christine K Rasmussen, Mads Hald Andersen, Michael Douglas Crowther, Inge Marie Svane, Marco Donia
Uncoupling CD4+ TIL-mediated tumor killing from JAK-signaling in melanoma. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Sidsel Pedersen, Rikke B Holmstroem, Annika von Heymann, Laerke K Tolstrup, Kasper Madsen, Morten Aagaard Petersen, Charlotte A Haslund, Christina H Ruhlmann, Henrik Schmidt, Christoffer Johansen, Inge Marie Svane, Eva Ellebaek
Quality of life and mental health in real-world patients with resected stage III/IV melanoma receiving adjuvant immunotherapy. Acta oncologica (Stockholm, Sweden) 62 (1) (2023)
Rikke Boedker Holmstroem, Emilie Kristine Dahl, Morten Helms, Henrik Vedel Nielsen, Janne Bayer Andersen, Jacob Tveiten Bjerrum, Inge Marie Svane, Eva Ellebaek, Jakob Benedict Seidelin
Tofacitinib and faecal microbiota transplantation in treating checkpoint inhibitor-induced enterocolitis: case report. BMJ open gastroenterology 9 (1) (2023)
Sidsel Pedersen, Rikke B Holmstroem, Annika von Heymann, Laerke K Tolstrup, Kasper Madsen, Morten Aagaard Petersen, Charlotte A Haslund, Christina H Ruhlmann, Henrik Schmidt, Christoffer Johansen, Inge Marie Svane, Eva Ellebaek
Quality of life and mental health in real-world patients with resected stage III/IV melanoma receiving adjuvant immunotherapy. Acta oncologica (Stockholm, Sweden) 62 (1) (2023)
Morten Nielsen, Tine Juul Monberg, Vibeke Sundvold, Benedetta Albieri, Dorrit Hovgaard, Michael Mørk Petersen, Anders Krarup-Hansen, Özcan Met, Ketil Camilio, Trevor Clancy, Richard Stratford, Baldur Sveinbjornsson, Øystein Rekdal, Niels Junker, Inge Marie Svane
LTX-315 and adoptive cell therapy using tumor-infiltrating lymphocytes generate tumor specific T cells in patients with metastatic soft tissue sarcoma. Oncoimmunology 13 (1) (2023)
Sidsel Pedersen, Rikke B Holmstroem, Annika von Heymann, Laerke K Tolstrup, Kasper Madsen, Morten Aagaard Petersen, Charlotte A Haslund, Christina H Ruhlmann, Henrik Schmidt, Christoffer Johansen, Inge Marie Svane, Eva Ellebaek
Quality of life and mental health in real-world patients with resected stage III/IV melanoma receiving adjuvant immunotherapy. Acta oncologica (Stockholm, Sweden) (2023)
Rikke Boedker Holmstroem, Emilie Kristine Dahl, Morten Helms, Henrik Vedel Nielsen, Janne Bayer Andersen, Jacob Tveiten Bjerrum, Inge Marie Svane, Eva Ellebaek, Jakob Benedict Seidelin
Tofacitinib and faecal microbiota transplantation in treating checkpoint inhibitor-induced enterocolitis: case report. BMJ open gastroenterology 9 (1) (2023)
Amalie Valentin, Anne Kirstine Hundahl Møller, Jesper Andreas Palshof, Bo Broberg, Eva Gravesen, Inge Marie Svane, Ditte Hansen
Combination therapy with immune check point inhibitors and acute kidney injury. Acta oncologica (Stockholm, Sweden) (2023)
Olga Zimmermannova, Alexandra Gabriela Ferreira, Ervin Ascic, Marta Velasco Santiago, Ilia Kurochkin, Morten Hansen, Özcan Met, Inês Caiado, Ilja E Shapiro, Justine Michaux, Marion Humbert, Diego Soto-Cabrera, Hreinn Benonisson, Rita Silvério-Alves, David Gomez-Jimenez, Carina Bernardo, Monika Bauden, Roland Andersson, Mattias Höglund, Kenichi Miharada, Yukio Nakamura, Stephanie Hugues, Lennart Greiff, Malin Lindstedt, Fábio F Rosa, Cristiana F Pires, Michal Bassani-Sternberg, Inge Marie Svane, Carlos-Filipe Pereira
Restoring tumor immunogenicity with dendritic cell reprogramming. Science immunology 8 (85) (2023)
Morten Nielsen, Tine Juul Monberg, Vibeke Sundvold, Benedetta Albieri, Dorrit Hovgaard, Michael Mørk Petersen, Anders Krarup-Hansen, Özcan Met, Ketil Camilio, Trevor Clancy, Richard Stratford, Baldur Sveinbjornsson, Øystein Rekdal, Niels Junker, Inge Marie Svane
LTX-315 and adoptive cell therapy using tumor-infiltrating lymphocytes generate tumor specific T cells in patients with metastatic soft tissue sarcoma. Oncoimmunology 13 (1) (2023)
Morten Nielsen, Tine Juul Monberg, Vibeke Sundvold, Benedetta Albieri, Dorrit Hovgaard, Michael Mørk Petersen, Anders Krarup-Hansen, Özcan Met, Ketil Camilio, Trevor Clancy, Richard Stratford, Baldur Sveinbjornsson, Øystein Rekdal, Niels Junker, Inge Marie Svane
LTX-315 and adoptive cell therapy using tumor-infiltrating lymphocytes generate tumor specific T cells in patients with metastatic soft tissue sarcoma. Oncoimmunology 13 (1) (2023)
Rikke Boedker Holmstroem, Emilie Kristine Dahl, Morten Helms, Henrik Vedel Nielsen, Janne Bayer Andersen, Jacob Tveiten Bjerrum, Inge Marie Svane, Eva Ellebaek, Jakob Benedict Seidelin
Tofacitinib and faecal microbiota transplantation in treating checkpoint inhibitor-induced enterocolitis: case report. BMJ open gastroenterology 9 (1) (2023)
Sidsel Pedersen, Rikke B Holmstroem, Annika von Heymann, Laerke K Tolstrup, Kasper Madsen, Morten Aagaard Petersen, Charlotte A Haslund, Christina H Ruhlmann, Henrik Schmidt, Christoffer Johansen, Inge Marie Svane, Eva Ellebaek
Quality of life and mental health in real-world patients with resected stage III/IV melanoma receiving adjuvant immunotherapy. Acta oncologica (Stockholm, Sweden) 62 (1) (2023)
Tine Juul Monberg, Troels Holz Borch, Inge Marie Svane, Marco Donia
TIL Therapy: Facts and Hopes. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Simone Kloch Bendtsen, Maria Perez-Penco, Mie Linder Hübbe, Evelina Martinenaite, Morten Orebo Holmström, Stine Emilie Weis-Banke, Nicolai Grønne Jørgensen, Mia Aaboe Jørgensen, Shamaila Munir Ahmad, Kasper Mølgaard Jensen, Christina Friese, Mia Thorup Lundsager, Astrid Zedlitz Johansen, Marco Carretta, Niels Odum, Özcan Met, Inge Marie Svane, Daniel Hargbøl Madsen, Mads Hald Andersen
Peptide vaccination activating Galectin-3-specific T cells offers a novel means to target Galectin-3-expressing cells in the tumor microenvironment. Oncoimmunology 11 (1) (2022)
Anders Handrup Kverneland, Ole Østergaard, Kristina Bennet Emdal, Inge Marie Svane, Jesper Velgaard Olsen
Differential ultracentrifugation enables deep plasma proteomics through enrichment of extracellular vesicles. Proteomics (2022)
Morten Nielsen, Mario Presti, Zsófia M Sztupinszki, Agnete Witness Præst Jensen, Arianna Draghi, Christopher Aled Chamberlain, Aimilia Schina, Christina Westmose Yde, John B Wojcik, Zoltan Szallasi, Michael Douglas Crowther, Inge Marie Svane, Marco Donia
Coexisting Alterations of MHC Class I Antigen Presentation and IFNγ Signaling Mediate Acquired Resistance of Melanoma to Post-PD-1 Immunotherapy. Cancer immunology research 10 (10) (2022)
Rikke Boedker Holmstroem, Ole Haagen Nielsen, Søren Jacobsen, Lene Buhl Riis, Susann Theile, Jacob Tveiten Bjerrum, Peter Vilmann, Julia Sidenius Johansen, Mogens Karsbøl Boisen, Rikke Helene Løvendahl Eefsen, Inge Marie Svane, Dorte Lisbet Nielsen, Inna Markovna Chen
COLAR: open-label clinical study of IL-6 blockade with tocilizumab for the treatment of immune checkpoint inhibitor-induced colitis and arthritis. Journal for immunotherapy of cancer 10 (9) (2022)
Silje Haukali Omland, Jacob Secher Ejlertsen, Dorrit Krustrup, Rikke Louise Christensen, Inge Marie Svane, Uffe Hoegh Olesen, Merete Haedersdal
Feasibility of Intratumoral Anti-PD1 as Treatment of Human Basal Cell Carcinoma: An Explorative Study with Adjuvant Ablative Fractional Laser. Cancers 14 (23) (2022)
Sofie Kirial Mørk, Mohammad Kadivar, Kalijn Fredrike Bol, Arianna Draghi, Marie Christine Wulff Westergaard, Signe Koggersbøl Skadborg, Nana Overgaard, Anders Bundgård Sørensen, Ida Svahn Rasmussen, Lars Vibe Andreasen, Christina Westmose Yde, Thomas Trolle, Christian Garde, Jens Friis-Nielsen, Nis Nørgaard, Dennis Christensen, Jens Vindahl Kringelum, Marco Donia, Sine Reker Hadrup, Inge Marie Svane
Personalized therapy with peptide-based neoantigen vaccine (EVX-01) including a novel adjuvant, CAF®09b, in patients with metastatic melanoma. Oncoimmunology 11 (1) (2022)
Joachim Stoltenborg Granhøj, Agnete Witness Præst Jensen, Mario Presti, Özcan Met, Inge Marie Svane, Marco Donia
Tumor-infiltrating lymphocytes for adoptive cell therapy: recent advances, challenges, and future directions. Expert opinion on biological therapy 22 (5) (2022)
Silje Haukali Omland, Jacob Secher Ejlertsen, Dorrit Krustrup, Rikke Louise Christensen, Inge Marie Svane, Uffe Hoegh Olesen, Merete Haedersdal
Feasibility of Intratumoral Anti-PD1 as Treatment of Human Basal Cell Carcinoma: An Explorative Study with Adjuvant Ablative Fractional Laser. Cancers 14 (23) (2022)
Martin Lauss, Marco Donia, Inge Marie Svane, Göran Jönsson
B Cells and Tertiary Lymphoid Structures: Friends or Foes in Cancer Immunotherapy? Clinical cancer research : an official journal of the American Association for Cancer Research 28 (9) (2022)
Silje Haukali Omland, Jacob Secher Ejlertsen, Dorrit Krustrup, Rikke Louise Christensen, Inge Marie Svane, Uffe Hoegh Olesen, Merete Haedersdal
Feasibility of Intratumoral Anti-PD1 as Treatment of Human Basal Cell Carcinoma: An Explorative Study with Adjuvant Ablative Fractional Laser. Cancers 14 (23) (2022)
Inna Markovna Chen, Julia S Johansen, Susann Theile, Jessica X Hjaltelin, Sif Ingibergsdóttir Novitski, Soren Brunak, Jane P Hasselby, Gro L Willemoe, Torben Lorentzen, Kasper Madsen, Benny V Jensen, Eva E Wilken, Poul Geertsen, Claus Preibisch Behrens, Christian Pállson Nolsøe, Kirstine L Hermann, Inge Marie Svane, Dorte Lisbet Nielsen
Randomized Phase II Study of Nivolumab With or Without Ipilimumab Combined With Stereotactic Body Radiotherapy for Refractory Metastatic Pancreatic Cancer (CheckPAC). Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (27) (2022)
Sidsel Pedersen, Kirstine Ostenfeld Larsen, Alex Hørby Christensen, Inge Marie Svane, Bo Zerahn, Eva Ellebaek
Cardiotoxicity in metastatic melanoma patients treated with BRAF and MEK inhibitors in a real-world setting. Acta oncologica (Stockholm, Sweden) (2021)
Nicolai Grønne Jørgensen, Jeanette Kaae, Jacob Handlos Grauslund, Özcan Met, Signe Ledou Nielsen, Ayako Wakatsuki Pedersen, Inge Marie Svane, Eva Ehrnrooth, Mads Hald Andersen, Claus Zachariae, Lone Skov
Vaccination against PD-L1 with IO103 a Novel Immune Modulatory Vaccine in Basal Cell Carcinoma: A Phase IIa Study. Cancers 13 (4) (2021)
Maria D'Souza, Mette Bagger, Mark Alberti, Morten Malmborg, Morten Schou, Christian Torp-Pedersen, Gunnar Gislason, Inge Marie Svane, Jens Folke Kiilgaard
Immune Checkpoint Inhibitor Treatment and Ophthalmologist Consultations in Patients with Malignant Melanoma or Lung Cancer-A Nationwide Cohort Study. Cancers 14 (1) (2021)
Julie Westerlin Kjeldsen, Cathrine Lund Lorentzen, Evelina Martinenaite, Eva Ellebaek, Marco Donia, Rikke Boedker Holmstroem, Tobias Wirenfeldt Klausen, Cecilie Oelvang Madsen, Shamaila Munir Ahmed, Stine Emilie Weis-Banke, Morten Orebo Holmström, Helle Westergren Hendel, Eva Ehrnrooth, Mai-Britt Zocca, Ayako Wakatsuki Pedersen, Mads Hald Andersen, Inge Marie Svane
A phase 1/2 trial of an immune-modulatory vaccine against IDO/PD-L1 in combination with nivolumab in metastatic melanoma. Nature medicine (2021)
Morten Fink, Anders Schwartz Vittrup, Lars Bastholt, Inge Marie Svane, Marco Donia, Adam A Luczak, Christina Halgaard Bruvik Ruhlmann, Louise Mahncke Guldbrandt, Ulrich Heide Koehler, Mette Lerche Winther, Eva Ellebaek, Charlotte Aaquist Haslund, Henrik Schmidt
Comparison of Efficacy in Patients with Metastatic Melanoma Treated with Ipilimumab and Nivolumab Who Did or Did Not Discontinue Treatment Due to Immune-Related Adverse Events: A Real-World Data Study. Cancers 13 (21) (2021)
Silje Haukali Omland, Emily Cathrine Wenande, Inge Marie Svane, Joshua Tam, Uffe Hoegh Olesen, Merete Haedersdal
Laser Immunotherapy: A Potential Treatment Modality for Keratinocyte Carcinoma. Cancers 13 (21) (2021)
Uffe Klausen, Nicolai Grønne Dahlager Jørgensen, Jacob Handlos Grauslund, Shamaila Munir Ahmad, Anne Ortved Gang, Evelina Martinenaite, Stine Emilie Weis-Banke, Marie Fredslund Breinholt, Guy Wayne Novotny, Julie Westerlin Kjeldsen, Morten Orebo Holmström, Lone Bredo Pedersen, Christian Bjørn Poulsen, Per Boye Hansen, Özcan Met, Inge Marie Svane, Carsten Utoft Niemann, Lars Møller Pedersen, Mads Hald Andersen
An immunogenic first-in-human immune modulatory vaccine with PD-L1 and PD-L2 peptides is feasible and shows early signs of efficacy in follicular lymphoma. Oncoimmunology 10 (1) (2021)
Uffe Klausen, Nicolai Grønne Dahlager Jørgensen, Jacob Handlos Grauslund, Shamaila Munir Ahmad, Anne Ortved Gang, Evelina Martinenaite, Stine Emilie Weis-Banke, Marie Fredslund Breinholt, Guy Wayne Novotny, Julie Westerlin Kjeldsen, Morten Orebo Holmström, Lone Bredo Pedersen, Christian Bjørn Poulsen, Per Boye Hansen, Özcan Met, Inge Marie Svane, Carsten Utoft Niemann, Lars Møller Pedersen, Mads Hald Andersen
An immunogenic first-in-human immune modulatory vaccine with PD-L1 and PD-L2 peptides is feasible and shows early signs of efficacy in follicular lymphoma. Oncoimmunology 10 (1) (2021)
Mario Presti, Marie Christine Wulff Westergaard, Arianna Draghi, Christopher Aled Chamberlain, Aishwarya Gokuldass, Inge Marie Svane, Marco Donia
The effects of targeted immune-regulatory strategies on tumor-specific T-cell responses in vitro. Cancer immunology, immunotherapy : CII 70 (6) (2020)
Marie Christine Wulff Westergaard, Katy Milne, Magnus Pedersen, Thomas Hasselager, Lars Rønn Olsen, Michael S Anglesio, Troels Holz Borch, Mia Kennedy, Gillian Briggs, Stacey Ledoux, Caroline Kreuzinger, Isabel von der Decken, Marco Donia, Dan Cacsire Castillo-Tong, Brad H Nelson, Inge Marie Svane
Changes in the Tumor Immune Microenvironment during Disease Progression in Patients with Ovarian Cancer. Cancers 12 (12) (2020)
Sunil Kumar Saini, Tripti Tamhane, Raghavendra Anjanappa, Ankur Saikia, Sofie Ramskov, Marco Donia, Inge Marie Svane, Søren Nyboe Jakobsen, Maria Garcia-Alai, Martin Zacharias, Rob Meijers, Sebastian Springer, Sine Reker Hadrup
Empty peptide-receptive MHC class I molecules for efficient detection of antigen-specific T cells. Science immunology 4 (37) (2020)
Stine Emilie Weis-Banke, Mie Linder Hübbe, Morten Orebo Holmström, Mia Aaboe Jørgensen, Simone Kloch Bendtsen, Evelina Martinenaite, Marco Carretta, Inge Marie Svane, Niels Ødum, Ayako Wakatsuki Pedersen, Özcan Met, Daniel Hargbøl Madsen, Mads Hald Andersen
The metabolic enzyme arginase-2 is a potential target for novel immune modulatory vaccines. Oncoimmunology 9 (1) (2020)
Nadia Viborg, Sofie Ramskov, Rikke Sick Andersen, Theo Sturm, Tim Fugmann, Amalie Kai Bentzen, Vibeke Mindahl Rafa, Per Thor Straten, Inge Marie Svane, Özcan Met, Sine Reker Hadrup
T cell recognition of novel shared breast cancer antigens is frequently observed in peripheral blood of breast cancer patients. Oncoimmunology 8 (12) (2019)
Joanna Walkowska, Thomas Kallemose, Göran Jönsson, Mats Jönsson, Ove Andersen, Mads Hald Andersen, Inge Marie Svane, Anne Langkilde, Mef Christina Nilbert, Christina Therkildsen
Immunoprofiles of colorectal cancer from Lynch syndrome. Oncoimmunology 8 (1) (2018)

Inge Marie Svane.css-eqlu8i{font-size:small;padding-left:4px;} (Inge M Svane)

Publication Activity (10 Years)

Top Topics

Top Venues

Inge Marie Svane (Inge M Svane)